Managing COVID-19 in Patients With Cancer: A Double Blow for Oncologists.
作者信息
Sahu Kamal Kant, Jindal Vishal, Siddiqui Ahmad Daniyal
机构信息
Department of Internal Medicine, Saint Vincent Hospital, Worcester, MA.
Department of Hematology and Oncology, William Beaumont Hospital, Oakland University, Royal Oak, MI.
出版信息
JCO Oncol Pract. 2020 May;16(5):223-225. doi: 10.1200/OP.20.00167. Epub 2020 Apr 17.
Abstract
摘要
相似文献
1
Managing COVID-19 in Patients With Cancer: A Double Blow for Oncologists.癌症患者的新冠病毒病管理：肿瘤学家面临的双重打击
JCO Oncol Pract. 2020 May;16(5):223-225. doi: 10.1200/OP.20.00167. Epub 2020 Apr 17.
2
Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: young oncologists' perspective.在意大利 2019 冠状病毒病（COVID-19）传播期间的癌症护理：青年肿瘤学家的观点。
ESMO Open. 2020 Mar;5(2). doi: 10.1136/esmoopen-2020-000759.
3
Managing patients with cancer in the COVID-19 era.在新冠疫情时代管理癌症患者。
Eur J Cancer. 2020 Jun;132:5-7. doi: 10.1016/j.ejca.2020.03.028. Epub 2020 Apr 11.
4
Risk of COVID-19 in Patients With Cancer.癌症患者感染新型冠状病毒肺炎的风险
JAMA Oncol. 2020 Sep 1;6(9):1471-1472. doi: 10.1001/jamaoncol.2020.2586.
5
Risk of COVID-19 in Patients With Cancer.癌症患者感染新型冠状病毒肺炎的风险
JAMA Oncol. 2020 Sep 1;6(9):1471. doi: 10.1001/jamaoncol.2020.2583.
6
Risk of COVID-19 in Patients With Cancer.癌症患者感染新型冠状病毒肺炎的风险
JAMA Oncol. 2020 Sep 1;6(9):1469-1470. doi: 10.1001/jamaoncol.2020.2577.
7
Risk of COVID-19 in Patients With Cancer.癌症患者感染新型冠状病毒肺炎的风险
JAMA Oncol. 2020 Sep 1;6(9):1470-1471. doi: 10.1001/jamaoncol.2020.2580.
8
Risk of COVID-19 for patients with cancer.癌症患者感染新冠病毒的风险。
Lancet Oncol. 2020 Apr;21(4):e181. doi: 10.1016/S1470-2045(20)30149-2. Epub 2020 Mar 3.
9
Risk of COVID-19 for patients with cancer.癌症患者感染新型冠状病毒肺炎的风险。
Lancet Oncol. 2020 Apr;21(4):e180. doi: 10.1016/S1470-2045(20)30150-9. Epub 2020 Mar 3.
10
Risk of SARS-CoV-2 Diffusion when Performing Minimally Invasive Surgery During the COVID-19 Pandemic.在新冠疫情期间进行微创手术时SARS-CoV-2传播的风险
Eur Urol. 2020 Jul;78(1):e12-e13. doi: 10.1016/j.eururo.2020.04.015. Epub 2020 Apr 13.
引用本文的文献
1
Evaluation of clinical outcomes, laboratory and imaging data of patients with solid tumor infected with COVID-19 infection.对感染新型冠状病毒肺炎的实体瘤患者的临床结局、实验室及影像学数据进行评估。
Int J Biochem Mol Biol. 2022 Dec 15;13(6):77-86. eCollection 2022.
2
Mechanism and Management of Checkpoint Inhibitor-Related Toxicities in Genitourinary Cancers.泌尿生殖系统癌症中检查点抑制剂相关毒性的机制与管理
Cancers (Basel). 2022 May 17;14(10):2460. doi: 10.3390/cancers14102460.
3
Hematopoietic Stem Cell Transplantation During the Era of COVID-19 in Queen Rania Children's Hospital.新冠疫情时代拉尼亚王后儿童医院的造血干细胞移植
Mater Sociomed. 2021 Jun;33(2):131-137. doi: 10.5455/msm.2021.33.131-137.
4
Treatment of Patients with Mental Illness Amid A Global COVID-19 Pandemic.全球 COVID-19 大流行期间精神疾病患者的治疗。
Adv Exp Med Biol. 2021;1318:759-771. doi: 10.1007/978-3-030-63761-3_42.
5
Challenges of Cellular Therapy During the COVID-19 Pandemic.2019冠状病毒病大流行期间细胞治疗面临的挑战
Adv Exp Med Biol. 2021;1318:657-672. doi: 10.1007/978-3-030-63761-3_36.
6
COVID-19 in Patients with Cancer.癌症患者中的 COVID-19。
Adv Exp Med Biol. 2021;1318:315-331. doi: 10.1007/978-3-030-63761-3_18.
7
Protective measures for patients with advanced cancer during the Sars-CoV-2 pandemic: Quo vadis?在 SARS-CoV-2 大流行期间，晚期癌症患者的保护措施：何去何从？
Clin Exp Metastasis. 2021 Jun;38(3):257-261. doi: 10.1007/s10585-021-10083-1. Epub 2021 Mar 23.
8
Taking a step down on the reconstruction ladder for head and neck reconstruction during the COVID-19 pandemic.在 COVID-19 大流行期间，对头颈重建进行重建阶梯式降级。
BMC Surg. 2021 Mar 8;21(1):120. doi: 10.1186/s12893-021-01134-1.
9
Current Perspectives of convalescent plasma therapy in COVID-19.COVID-19 恢复期血浆疗法的现状。
Acta Biomed. 2020 Nov 10;91(4):e2020175. doi: 10.23750/abm.v91i4.10681.
10
The characteristics of cancerous patients infected with COVID-19 in hospital setting.在院新冠病毒感染癌症患者的特点。
Acta Biomed. 2020 Nov 10;91(4):e2020145. doi: 10.23750/abm.v91i4.10175.
本文引用的文献
1
Comprehensive update on current outbreak of novel coronavirus infection (2019-nCoV).新型冠状病毒感染（2019-nCoV）当前疫情的全面更新。
Ann Transl Med. 2020 Mar;8(6):393. doi: 10.21037/atm.2020.02.92.
2
Risk of COVID-19 for patients with cancer.癌症患者感染新型冠状病毒肺炎的风险。
Lancet Oncol. 2020 Apr;21(4):e180. doi: 10.1016/S1470-2045(20)30150-9. Epub 2020 Mar 3.
3
Risk of COVID-19 for patients with cancer.癌症患者感染新冠病毒的风险。
Lancet Oncol. 2020 Apr;21(4):e181. doi: 10.1016/S1470-2045(20)30149-2. Epub 2020 Mar 3.
4
[The differential diagnosis of pulmonary infiltrates in cancer patients during the outbreak of the 2019 novel coronavirus disease].[2019年新型冠状病毒病疫情期间癌症患者肺部浸润的鉴别诊断]
Zhonghua Zhong Liu Za Zhi. 2020 Apr 23;42(4):305-311. doi: 10.3760/cma.j.cn112152-20200303-00166.
5
Coronavirus disease-2019: An update on third coronavirus outbreak of 21st century.2019冠状病毒病：21世纪第三次冠状病毒疫情最新情况
QJM. 2020 May 1;113(5):384-386. doi: 10.1093/qjmed/hcaa081.
6
[Drug interaction monitoring of lopinavir/ritonavir in COVID-19 patients with cancer].[新冠肺炎合并癌症患者中洛匹那韦/利托那韦的药物相互作用监测]
Zhonghua Nei Ke Za Zhi. 2020 May 1;59(5):400-404. doi: 10.3760/cma.j.cn112138-20200219-00097.
7
[Several suggestion of operation for colorectal cancer under the outbreak of Corona Virus Disease 19 in China].[中国新型冠状病毒肺炎疫情下结直肠癌的几点手术建议]
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Feb 19;23(3):9-11. doi: 10.3760/cma.j.issn.1671-0274.2020.03.002.
8
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China.新型冠状病毒肺炎（SARS-CoV-2）感染的癌症患者：一项中国全国性分析。
Lancet Oncol. 2020 Mar;21(3):335-337. doi: 10.1016/S1470-2045(20)30096-6. Epub 2020 Feb 14.
9
Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment.四例新型冠状病毒肺炎患者采用中西医结合治疗的临床特点和治疗经过。
Biosci Trends. 2020 Mar 16;14(1):64-68. doi: 10.5582/bst.2020.01030. Epub 2020 Feb 9.
10
A rare case of rituximab induced interstitial lung disease.1例罕见的利妥昔单抗诱导的间质性肺疾病。
Lung India. 2016 Jul-Aug;33(4):472-3. doi: 10.4103/0970-2113.184960.
Zotero 插件